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We studied the activities of several kinds of bbbbb -glucans,
including  sonifilan,  grifolan, Sclerotinia  sclerotiorum
glucan, laminarin and zym osan, on m acrophages. Pre-
culture of macrophages with inactive bbbbb -glucans rendered
the cells unresponsive to subsequent stimulation with
grifolan, suggesting a specific pathway in the bbbbb -glucan
structure. The im portance of protein C and phosphory-
lation of m itogen-activated protein kinase was dem on-
strated in the activation with grifolan or zym osan. Im -
munoprecipitation of com plem ent receptor (CR3), co-
precipitated other proteins carrying phosphotyrosine
residues in stimulation with grifolan. These data sug-
gest that protein kinase C and tyrosine kinases are es-
sential for signal transduction, and that CR3 might par-
ticipate in the activation through interaction with oth-
er intracellular proteins.
Keywords: b -glucan, macrophage, tyrosine phophorylation
Leukocyte activation by (1®®®®® 3)-bbbbb -D-
glucans
Yoshiyuki Adachi
CA, Mitsuhiro Okazaki, Naohito
Ohno and Toshiro Yadomae
Laboratory of Immunopharmacology of Microbial
Products, Tokyo College of Pharmacy, 1432-1
Horinouchi, Hachioji-shi, Tokyo 192-03, Japan
CACorresponding author
Tel: +81 426 76 5599
Fax: +81 426 75 5570
Email: adachiyo@ ps.toyaku.ac.jp
Introduction
M acrophages are differentiated cells in the mononu-
clear phagocyte system [1]. They are widely distrib-
uted throughout the body and have a crucial function
in defending the body against tumor cells or invasion
by a wide variety of microorganisms. Fungal-derived
(1® 3)-b -D-glucans  are  known to  activate  a  variety
of macrophage functions [2±4]. In a previous study,
we reported that grifolan, a gel-forming (1® 3)-b -D-
glucan from liquid-cultured mycelium of Grifola fron-
dosa, induced antitum or activities against murine ex-
perimental tumors [5]. During the activation step, the
im portance of macrophages was suggested by a block-
ade of the macrophage phagocyte function when car-
rageenan was injected into the host [6]. M acrophag-
es are also known as cytokine-producing cells, upon
stimulation with products from various microorgan-
isms [7]. It is clear that those cytokines activate the
host defense function [8]. As glucans are able to acti-
vate the immune system and as cytokines play a key
role in stim ulating host defense activity, there is much
interest in investigating the activity of  b -glucans in
cytokine production. We also studied signal pathways
required  for  the  macrophage  activation  induced  by
b -glucans. The signal pathway of the  b -glucan-acti-
vated m acrophage is discussed here.
Materials and methods
Mice
M ale Institute for Cancer Research (ICR) m ice were
purchased from Japan S.L.C. (Hamamatsu, Japan) and
used at 6±8 weeks of age.
Reagents
Lipopolysaccharide obtained from  Escherichia coli
O111 and sodium orthovanadate were purchased from
Sigma Chemical Co. (St Louis, M issouri, USA). H-7,
HA1004, W-7 and W-5 were purchased from Seika-
gaku Kogyo Co. Ltd (Tokyo, Japan). Genistein and
tyrphostin  w ere  purchased  from   Gibco-BRL   Life
Technologies (Grand Island, M aryland, USA). Her-
bimycin  A (herbim ycin) was purchased from  Wako
Pure Chemical Co. Ltd (Osaka, Japan).
Preparation of b -glucans
Grifolan was prepared by the method described pre-
viously  [5].  Sonifilan was donated by Kaken Phar-
maceutical  Co.  Ltd  (Tokyo,  Japan).  Laminarin  and
dextran  were  purchased  from  Sigma  Chemical  Co.
and Seikagaku Kogyo Co. Ltd, respectively. Zymosan
A and zymocel were purchased from Sigma Chemi-
cal Co. and Alpha-Beta Technology Inc. (Worcester,
M assachusetts, USA), respectively.
Culture of macrophage cell line
The  m ouse  m acrophage-like  cell  line  R AW 264.7
(Riken Cell Bank, Tsukuba,  Japan) was cultured to
confluence  in  R oswell  Park  M em orial  Institute
(RPMI) 1640/10%  fetal calf serum. RAW 264.7 cells
were suspended at a cell density of 2.5 ´ 10
6 cells/m l
in RPM I 1640/10%  fetal calf serum.  The cells were
stim ulated with or without grifolan (100, 500 m g/m l)
or lipopolysaccharide (10 mg/m l) at 37Ê C for 24±48
h in a humidified 5%  CO 2 incubator. After the incu-252         Mediators of Inflammation ￿ Vol 6 ￿ 1997
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bation, culture supernatant was collected by centrif-
ugation at 300 g for 5 min. Macrophages adhering to
the culture plate were lysed in distilled water by re-
peated freezing and thawing (three times), followed
by  th e  ad dition  of  a  tw ofo ld  concentration   of
RPMI 1640 and filtration through a syringe filter unit
(0.20 m m , Corning, New York, NY, USA).
Preparation of murine peritoneal macrophages
Peritoneal macrophages were isolated from ICR mice,
injected intraperitoneally with 2 ml  proteospeptone
3 days  before peritoneal lavage with 14 ml Hanks’
balanced salt  solution  (HBSS;  Nissui Pharmaceuti-
cal Co. Ltd, Tokyo, Japan) containing 5 mmol/l N -2-
hydroxyethylpiperazine-N -2-ethanesulphonic  acid
(Sigma Chemical Co.), 100 U/m l penicillin, 100 mg/
ml streptom ycin (M eiji Seika Kaisha Ltd, Tokyo, Ja-
pan) and 5 U/ml heparin (Wako Pure Chemical Co.
Ltd).  The cells  collected  were  washed  twice  with
RPM I 1640 and then cultured in RPMI 1640 contain-
ing  1%   heat-inactivated  fetal  calf  serum.  The  cells
were  allowed  to  adhere  to  a  96-well  culture  plate
(Sumitomo Bakelite Co. Ltd, Tokyo,  Japan) for 3 h
at  37Ê C  in  a  5%   CO2  incubator in  100  ml  culture
media.  T he  culture  was  then  w ashed  tw ice  with
100 m l/well of culture media to remove non-adherent
cells.
Determination of tumor necrosis factor (TNF)-a  by
enzyme-linked immunosorbent assay (ELISA)
For the ELISA system, a 96-well plate (MS 8596-F,
Sumitom o Bakelite Co. Ltd) was coated with rat anti-
m ouse TNF-a  m onoclonal antibody (mAb; Pharm in-
gen,  San  Diego,  California,  USA)  in  a  bicarbonate
buffer (pH 9.6). Uncoated binding sites in the w ells
were blocked with phosphate-buffered saline contain-
ing 0.25%  bovine serum albumin (Biocell Laborato-
ries, Carson, California, USA) and 0.05%  Tween 20
(Wako Pure Chemical Co. Ltd) (BPBST). The wells
were incubated with 50 ml of sample, culture super-
natant or cell lysate in duplicate at 37Ê C for 40 m in
and then exposed to rabbit polyclonal antim ouse TNF-
a  (Genzyme Co., Boston, Massachusetts, USA). The
plate  was  developed  using  peroxidase-labeled  goat
antirabbit im m unoglobulin (Ig)G (Organon Teknika,
West  Chester, Pennsylvania,  USA)  and  peroxidase
substrate  (3,3 Â 5,5 Â -tetramethylbenzidine  microwell
peroxidase  substrate  system;  Kirkegaard  and  Perry
Laboratories Inc., Gaithersburg, Maryland, USA). Al-
iquots of recombinant mouse TNF-a  (R& D Systems,
M inneapolis,  M innesota,  USA)  dissolved  in  50 ml
BPBST were used to construct a standard curve.
RNA isolation and Northern blot analysis
Total RNA was extracted from 1.0 ´ 10
7 cells by the
single-step guanidinium thiocyanate±phenol±chloro-
form method [9].  Total RNA (20 m g) was subjected
to  agarose±formaldehyde  gel  electrophoresis,  blot-
ted onto nylon filters, Hybond-N (Amersham  Corp.,
Arlington Heights,  Illinois, USA),  and cross-linked
by exposure to ultraviolet light for 5 min on each side.
The  filters  were  prehybridized  in  50%   form amide,
5 ´ saline  sodium   phosphate  ethylenediam inetetra-
acetic  acid  (SSPE ),  0.5%   sodium   dodecyl  sulfate,
5 ´ Denhardt’s solution, and 50 mg/ml salm on DNA
for  4 h  at  42Ê C.  Overnight  hybridization  was  per-
formed at 42Ê C in the same buffer containing 2 ´ 10
6
cpm/ml of the TNF-a  probes that had been radiola-
beled  with  (a -
32P)  deoxy  (d)CTP  (3000  Ci/mm ol;
Amersham) by the Megaprime DNA labeling system
(Amersham ). The TNF-a  probe was a 1.3-kb EcoRI
fragment in murine TNF-a  plasmid DNA, pJT-1 (S .
Natori, Tokyo University, Japan). This was follow ed
by  washes  in 2 ´ SSPE,  0.1%   sodium  dodecyl  sul-
fate at 45Ê C (2 ´ 15 min), in 1 ´ SSPE, 0.1%  sodium
dodecyl  sulfate  at  45Ê C  (1 ´ 30  m in)  and  then  in
0.1 ´ SSPE,  0.1%   sodium  dodecyl  sulfate  at  45Ê C
(1 ´ 30 min).  The filters were exposed to the im ag-
ing plate at room temperature for 3 h. The autoradio-
graphic signals were measured by a bio-imaging an-
alyzer (BAS 2000; Fuji Film, Tokyo, Japan).
Electrophoresis and Western blotting
Cellular extracts were subjected to sodium dodecyl
sulfate±polyacrylam ide  gel  electrophoresis  as  de-
scribed previously  [10].  After  separation with  10%
gels, the gels were washed and equilibrated in trans-
fer buffer for 15 min and then electrotransferred to a
polyvinyliden difluoride membrane. Imm unoblotting
of the membrane was performed after blocking non-
specific  binding  by  incubation  with  1%   bovine  se-
rum albumin and 0.05%  Tw een 20 in tris-hydroxyme-
thyl-amino methane (TRIS)-buffered saline at pH 7.5.
Detection was by a peroxidase-labeled antiphospho-
tyrosine  recombinant  antibody (RC20H;  Transduc-
tion Laboratories, Lexington, Kentucky, USA) and a
non-isotopic  chemilum inescent  system   (ECL, Am-
ersham ).
Immunoprecipitation of CR3 and its associating
proteins
Macrophages were cultured with various stim uli, and
then the cells were lysed with lysing buffer contain-
ing  20 mmol/l  T R IS  (pH 8.2),  140 m m ol/l  NaCl,
2 m mol/l  ethylenediam inetetraacetic  acid  (EDTA),
1%   B rij-58  (P ierce,  R o ckford,  Illino is,  U S A ),
5 mm ol/l iodoacetamide, aprotinin, leupeptin (10 mg/
m l),  1 m m ol/l  phenylm ethylsulfonyl  fluoride  and
1 m m ol/l  sodium   orthovanadate  [11].  T he  lysate,
which was preadsorbed with antimouse IgG antibody-
conjugated agarose, was incubated overnight (rock-Leukocyte  activation
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ing at 4Ê C) with anti-CR3 monoclonal antibody, and
then  antimurine  IgG  antibody-conjugated  agarose.
The precipitate was washed three times with lysing
buffer and resuspended in 2 ´  Laemmli buffer (4%
sodium  dodecyl  sulfate,  20%   glycerol,  120  m mol/l
TRIS,  pH  6.8,  and  0.01%   bromophenol  blue)  with
12%  2-mercaptoethanol,  boiled for 3  min and then
electrophoresed  through  10%   sodium  dodecyl  sul-
fate±polyacrylam ide  gel.  The  proteins  w ere  trans-
ferred to the polyvinyliden difluoride mem brane af-
ter  electrophoresis,  and  the  membrane  was  probed
with RC20H as described above.
Results
Effect of various b -glucans on TNF-a  production by
macrophages in vitro
Since grifolan was able to stimulate macrophages to
produce interleukin (IL)-1a , IL-6, and TNF-a  in vit-
ro, we investigated the question of w hether other sol-
uble and gel-form ing glucans are able to induce sim -
ilar cytokine production.  We found that RAW 264.7
cells cultured with 500 m g/ml of sonifilan, Sclerotin-
ia  sclerotiorum ,  lam inarin  and  dextran  for  24 h  at
37°C did not induce any release of TNF-a  (Table 1).
This result was further confirmed by Northern blot
analysis in which no expression of  TNF-a  messen-
ger (m)RNA was observed in culture with sonifilan,
lam inarin and dextran (data not shown) [12].  These
results indicated that grifolan is the only active gel-
forming b -glucan tested in this study.
Pretreatment effect of inactive b -glucans on grifolan-
inducible macrophage activation
To establish whether or not the inactive glucans could
be recognized by the macrophages, we investigated
the effect of various b -glucans on grifolan-inducible
TNF-a  release  by RAW 264.7 cells.  The  cells  were
cultured with 250 m g/ml grifolan in the presence of
100, 250 or 500 m g/m l of sonifilan, Sclerotinia scle-
rotiorum  glucan, lam inarin and dextran at 37°C for
12  h,  and the  TNF-a  concentration  in  each culture
supernatant was quantified by  ELISA. As shown in
Table 2, TNF-a  release was significantly reduced by
the pretreatm ent  with inactive glucans. Grifolan at-
taching or endocytosed by macrophages was also re-
duced by the pretreatm ent. It was therefore suggest-
ed that inactive b -glucans could be bound to the cell
surface to which grifolan would interact to stimulate
cytokine production.
Effect of protein kinase C or calmodulin on TNF-a
production induced with grifolan
To examine  the  intracellular  signaling  pathway  for
the TNF-a  induction by grifolan, the expression lev-
el of TNF-a  mRNA obtained from protein kinase C
inhibitor- or calmodulin antagonist-treated cells was
determ ined by Northern blotting analysis. H-7 or W-
7 was used as the effective inhibitor for protein ki-
nase  C  or  calm odulin,  respectively.  The  results  are
shown in Fig. 1.
With H-7, the mRNA of TNF-a  was reduced to 40
m mol/l, while the negative control reagent, HA1004,
did not affect the expression of mRNA. In contrast to
the protein kinase C inhibitor, the calmodulin antag-
onist, W-7, did not reduce the mRNA level of TNF-
a .  These data  suggest  that  protein  kinase C  has an
important role in inducing TNF-a  production.
Effect of inhibitors for tyrosine kinases on TNF-a
induction by b -glucan
Tyrosine phosphorylation had also been reported as
an im portant element in the signal transduction [13].
We therefore exam ined the pretreatm ent effect of ty-
rosine kinase inhibitors on TNF-a  production. All in-
hibitors of tyrosine kinases showed a significant in-
hibitory effect on the production of TNF-a , implying
that the activation pathways for this TNF-a  produc-
tion were regulated by tyrosine kinases (Fig.  2).  To
elucidate what phosphorylated protein was involved
in the  activation, we  extracted  the  cellular  proteins
and subjected them to Western blotting analysis us-
ing antiphosphotyrosine antibody. Fig. 3 clearly dem-
onstrates that m itogen-activated protein kinases have
two different  molecular  weight  enzymes,  at  42 000
and 44 000, phosphorylated by stimulation with zy-
mosan and grifolan. The results confirmed that tyro-
sine  phosphorylation  will  be  induced  by  cytokine-
inducible  b -glucans.
Table 1. Effect of various glucans on tumor necrosis factor (TNF)-
a  production by macrophages  in vitro. RAW264.7 cells were cul-
tured with several concentrations of glucans for 24 h at 37 °C in a
humidified CO2 incubator
Glucans (500  m g/ml) TNF-a  (ng/ml)
Grifolan 10.4
Sonifilan 1.4
Sclerotinia sclerotiorum  glucan 0.5
Laminarin 1.1
Dextran 0
Table 2. Inhibitory effect (%) of b -glucans on tumor necrosis fac-
tor-a  production induced with grifolan. RAW264.7 cells were cul-
tured with a mixture of grifolan and the glucans indicated
Glucans 100 m g/ml 250  m g/ml 500 m g/ml
Sonifilan 11.8 51.0 71.6
SSG 27.2 46.2 55.1
Laminarin 50.6 43.7 38.6
Dextran 0 0 4.4
SSG, Sclerotinia sclerotiorum   glucan.254         Mediators of Inflammation ￿ Vol 6 ￿ 1997
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Fig. 3. Phosphorylation of mitogen-activated protein kinase in
macrophage lysate induced with various stimuli. GRN, grifolan;
SPG, sonifilan; LAM, laminarin; ZyM, zymosan.
Fig. 2. Effect of tyrosine kinase inhibitors on the production of tumor necrosis factor
(TNF)-a  by RAW264.7. LPS, lipopolysaccharide; GRN, grifolan; ZyM, zymosan.
Fig. 1. Effect of signal transduction inhibitors on tumor necrosis factor (TNF)- a  messen-
ger RNA. Expression was induced with grifolan. RAW264.7 cells were stimulated with
grifolan (500 m g/ml) with and without inhibitors for 6 h at 37°C.
Fig. 4. Tyrosine phosphorylation of CR3-associating proteins. LPS,
lipopolysaccharide; GRN, grifolan; ZyM, zymosan; LAM, laminarin.Leukocyte  activation
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Tyrosine phosphorylation of 38 000 molecular weight
protein associating with CR3
Recently, Ross and his colleagues  [14] reported that
complement receptor type 3 (CR3)  was a  b -glucan
receptor. CR3 is a heterodim er transmembrane-type
cell-surface molecule distributed on phagocytes such
as macrophages and neutrophils [15]. The mechanism
of the signal transduction generated by ligand-bind-
ing to CR3 is not fully understood. We tried to deter-
mine whether there are phosphorylated proteins as-
so ciating   w ith   C R 3  after  th e  stim ulation   w ith
b -glucans.  The  m acrophages  w ere  incubated  with
several stim uli and then lysed with lysing buffer con-
taining Nonidet P-40, various protease inhibitors and
a phosphatase inhibitor.  The  cell lysate was immu-
noprecipitated with antimurine CR3 monoclonal an-
tibody and antirat IgG agarose. The precipitation was
loaded to sodium dodecyl sulfate±polyacrylamide gel
electrophoresis and blotted on the polyvinyliden di-
fluoride membrane. Phosphorylation was detected by
POX-conjugated  anti-phosphotyrosine  monoclonal
antibody.  Biotinylated  CR3  was  precipitated  with
CR 3  antibody,  and  the  m olecular  w eight  showed
165 000 and 95 000 by incubation with POX-conju-
gated streptavidin (data not shown). When the mem-
brane was probed with antiphosphotyrosine antibody,
at  least two positive bands em erged,  at  38 000  and
36 000  (Fig.  4).  In  a  com parison  of  the  stim uli,  li-
popolysaccharide  increased  the  phosphorylation  of
the 36 000 molecular weight protein with incubation
for 30 min, whereas grifolan and zym osan induced
phosphorylation of the 38 000 m olecular weight pro-
tein. These results suggest that the  b -glucans can in-
crease the phosphorylation of the 38 000 m olecular
weight protein associating with CR3 molecules.
Discussion
The present results show how  b -glucans activate mac-
rophages to produce various inflammatory cytokines
with  respect  to  the  intracellular  signaling  pathw ay.
Comparing structure±activity relationships in sever-
al  b -glucans,  we  found  that  grifolan  and  zym osan
were the only active  b -glucans tested in this study.
Zym osan  has  been  reported  to  be  a  strong  macro-
phage activator in both cytokine and superoxide pro-
duction [16]. Although, the morphology of grifolan
is not a particle form like that of zymosan, grifolan is
a unique gel-forming active b -glucan on the cytokine
induction.
W hen several inhibitors were used for tyrosine ki-
nases and protein kinase C, the im portance of those
kinases  for  cytokine  production  was  suggested.  It
seems  that  protein kinase  C in particular is closely
related to the expression of the TNF-a  mRNA, while
calm odulin  is  not.  In  the  case  of  tyrosine  kinases,
grifolan induced phosphorylation of mitogen-activat-
ed protein kinase, which is known to be an im portant
signal transduction element [13]. The recognition sys-
tem for the  b -glucans has recently been revealed as
CR3 [14], one of the integrin molecules. Soluble, in-
active  b -glucans  also  bind  to  CR3,  although  those
glucans had no effect on the cytokine production [14].
The present study showed that soluble  b -glucans
had an antagonistic effect on grifolan-induced TNF-
a  production. Grifolan might be effective for induc-
ing activation of CR3 molecules by cross-linking the
monomer CR3 to multim er. Petty and Todd [17] re-
ported  that  activation  of CR3  generated  integration
of a heteroreceptor molecule complex. It is possible
that some adapter proteins in cytoplasm  come together
with the integrated CR3 and other receptor molecules.
Our results show that activation of m acrophages by
grifolan  induces  such  protein  integration,  and  that
those  proteins  are  substrates  for  tyrosine  kinases.
Further work is needed to clarify the activation mech-
anism s in detail by stimulation with grifolan. How-
ever, this study provides some data for the understand-
ing of im munopharmacological effects of b -glucans
on the host defense.
Conclusions
Grifolan has potent cytokine-inducing activity in mac-
rophages.  The  intracellular  pathway  is  affected  by
protein  kinase  C  and  tyrosine  kinases,  such  as  m i-
togen-activated protein kinase. Furthermore, CR3, a
b -glucan receptor,  m ight take part  in the activation
by associating with the substrate for tyrosine kinas-
es.
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